PRCT · PROCEPT BioRobotics Corp · Webcasts, Transcripts & Audio
$23.80
+0.29 (+1.23%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.37B
Shares
57.54M
Volume · Nov 13
1.68M
Avg daily vol (3M)
1.26M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
PROCEPT BioRobotics Corp Webcasts
Earnings calls, investor updates, investor days and conferences for PROCEPT BioRobotics Corp (PRCT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
PROCEPT BioRobotics Corp (PRCT) Q3 2026 Earnings Call Transcript
Confident tone
Commercial launch and patient activation
Hydros installed-base transition and utilization
Near-term utilization and execution risks
Revenue
$98.29M
▲ 18% YoY Diluted EPS
$-0.46
Gross margin
66.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
PROCEPT BioRobotics Corp (PRCT) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-04
PROCEPT BioRobotics Corp (PRCT) Q2 2026 Earnings Call Transcript
Positive tone
Procedure growth shortfall in legacy AquaBeam accounts
Guidance and path to profitability
Hydros robotic system rollout
Revenue
$94.50M
▲ 19.3% YoY Diluted EPS
$-0.47
Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
PROCEPT BioRobotics Corp (PRCT) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
PROCEPT BioRobotics Corp (PRCT) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-29
PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Transcript
Confident tone
Revenue and procedure growth
Pricing discipline and ASP
Commercial realignment and launch team
Revenue
$83.13M
▲ 20.2% YoY Diluted EPS
$-0.56
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
PROCEPT BioRobotics Corp (PRCT) Q4 2025 Earnings Call Transcript
Positive tone
Capital system placements
Procedure growth and utilization
Profitability path and operating expenses
Revenue
$76.38M*
▲ 11.9% YoY Gross margin
60.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
PROCEPT BioRobotics Corp (PRCT) Q3 2025 Earnings Call Transcript
Positive tone
Procedure utilization / new account launches
U.S. capital systems / HYDROS placements
BPH market opportunity / therapy awareness
Revenue
$83.33M
▲ 42.8% YoY Diluted EPS
$-0.38
Gross margin
64.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
PROCEPT BioRobotics Corp (PRCT) Q2 2025 Earnings Call Transcript
Confident tone
HYDROS platform launch
Gross margin and path to profitability
WATER IV trial and prostate cancer
Revenue
$79.18M
▲ 48.4% YoY Diluted EPS
$-0.35
Gross margin
65.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
PROCEPT BioRobotics Corp (PRCT) Q1 2025 Earnings Call Transcript
Confident tone
Commercial execution and account launches
Revenue and unit growth
Capital equipment sales cycle and pipeline
Revenue
$69.16M
▲ 55.3% YoY Diluted EPS
$-0.45
Gross margin
63.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Transcript
Confident tone
HYDROS Robotic System Launch
BPH Market Share and Standard of Care
Revenue Growth and Procedures
Revenue
$68.24M*
▲ 56.6% YoY Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-28
PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Transcript
Confident tone
HYDROS Robotic System Launch
Prostate Cancer Clinical Study / WATER IV PCa
Q4 2024 Guidance and System Sales Outlook
Revenue
$58.37M
▲ 66.3% YoY Diluted EPS
$-0.40
Gross margin
63.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
PROCEPT BioRobotics Corp (PRCT) Q2 2024 Earnings Call Transcript
Confident tone
Revenue growth and U.S. system sales
Prostate cancer expansion and clinical studies
Gross margin and operating leverage
Revenue
$53.35M
▲ 61.2% YoY Diluted EPS
$-0.50
Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
PROCEPT BioRobotics Corp (PRCT) Q1 2024 Earnings Call Transcript
Confident tone
Revenue Growth and Financial Performance
U.S. Installed Base and Hospital Adoption
Prostate Cancer Opportunity and AUA Conference
Revenue
$44.54M
▲ 82.5% YoY Diluted EPS
$-0.51
Gross margin
56.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
PROCEPT BioRobotics Corp (PRCT) Q4 2023 Earnings Call Transcript
Confident tone
Revenue Growth and Utilization
BPH Standard of Care Strategy
IDN and Reimbursement
Revenue
$43.58M*
▲ 83.3% YoY Gross margin
48.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
PROCEPT BioRobotics Corp (PRCT) Q3 2023 Earnings Call Transcript
Revenue
$35.10M
▲ 72.5% YoY Diluted EPS
$-0.51
Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
PROCEPT BioRobotics Corp (PRCT) Q2 2023 Earnings Call Transcript
Revenue
$33.10M
▲ 98.3% YoY Diluted EPS
$-0.56
Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
PROCEPT BioRobotics Corp (PRCT) Q1 2023 Earnings Call Transcript
Revenue
$24.40M
▲ 71.9% YoY Diluted EPS
$-0.63
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
PROCEPT BioRobotics Corp (PRCT) Q4 2022 Earnings Call Transcript
Revenue
$23.78M*
▲ 134.6% YoY Gross margin
44.9%
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
PROCEPT BioRobotics Corp (PRCT) Q3 2022 Earnings Call Transcript
Revenue
$20.35M
▲ 134.8% YoY Diluted EPS
$-0.51
Gross margin
50.3%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
PROCEPT BioRobotics Corp (PRCT) Q2 2022 Earnings Call Transcript
Revenue
$16.69M
▲ 96.9% YoY Diluted EPS
$-0.43
Gross margin
50.8%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
PROCEPT BioRobotics Corp (PRCT) Q1 2022 Earnings Call Transcript
Revenue
$14.20M
▲ 97.4% YoY Diluted EPS
$-0.39
Gross margin
54.2%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
PROCEPT BioRobotics Corp (PRCT) Q4 2021 Earnings Call Transcript
Revenue
$10.14M*
Gross margin
44.5%
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
PROCEPT BioRobotics Corp (PRCT) Q3 2021 Earnings Call Transcript
Revenue
$8.67M
▲ 311.4% YoY Diluted EPS
$-1.22
Gross margin
48.9%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 webcasts
Key facts
CIK
1588978
CUSIP
74276L105
13F (30d)
203 filings
164 filers
Visit website
Investor relations